Clinical Trial: NCT04419402
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 2| Lead Sponsor: | Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
| Information Provided By: | Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
| Last Update Posted: | 2026-06-22 |
Study Overview
Brief Summary
This phase 2 randomised clinical trial will investigate the activity and safety of adding Lu-PSMA to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC) not previously treated with chemotherapy.
Official Title
ENZA-p: A Randomised Phase II Trial Using PSMA as a Therapeutic Agent and Prognostic Indicator in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide (ANZUP 1901)
Conditions
Metastatic Castration-Resistant Prostate Cancer
Intervention / Treatment
- Drug: Lu-PSMA
- Drug: Enzalutamide
Other Study ID Numbers
- ANZUP 1901
Start Date (Actual)
2020-08-17
Primary Completion Date (Actual)
2024-04-12
Study Completion Date (Estimated)
2026-12-01
Enrollment (Actual)
162
Study Type
Interventional
Phase
Phase 2
| Lead Sponsor: | Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
| Information Provided By: | Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
| Last Update Posted: | 2026-06-22 |
Study Overview
Brief Summary
This phase 2 randomised clinical trial will investigate the activity and safety of adding Lu-PSMA to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC) not previously treated with chemotherapy.
Official Title
ENZA-p: A Randomised Phase II Trial Using PSMA as a Therapeutic Agent and Prognostic Indicator in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide (ANZUP 1901)
Conditions
Metastatic Castration-Resistant Prostate Cancer
Intervention / Treatment
- Drug: Lu-PSMA
- Drug: Enzalutamide
Other Study ID Numbers
- ANZUP 1901
Start Date (Actual)
2020-08-17
Primary Completion Date (Actual)
2024-04-12
Study Completion Date (Estimated)
2026-12-01
Enrollment (Actual)
162
Study Type
Interventional
Phase
Phase 2